Stefanie Z.
- Country
- Germany
- Department
- -
Research Overview
- A Phase 3 Study of MK-2870 Versus Investigator’s Choice of Non-platinum Chemotherapy in Participants with Pretreated Locally Advanced or Metastatic Urothelial Carcinoma
- Phase 1b/2 Study of PF-08634404 Monotherapy and Combination Therapy in Adults with Locally Advanced or Metastatic Renal Cell Carcinoma
- Phase II Trial of BMS-986365 Switch in Metastatic Castration-Sensitive Prostate Cancer with Suboptimal PSA Response after ADT and ARPI
Data & Insights
Has run more than one trial at 226 of 390 partner sites.
Specializations
Urological Oncology
Specializes in research involving advanced urothelial cancer treatments, particularly focusing on novel therapeutic combinations and immunotherapy approaches for bladder cancer management.
- Muscle-invasive urothelial carcinoma
- Metastatic bladder cancer interventions
- Advanced urothelial cancer therapies
Investigates innovative treatment strategies including immunotherapy combinations and targeted therapies for various stages of disease.
Prostate Cancer Research
Conducts extensive research in metastatic prostate cancer treatment, with particular emphasis on both castration-sensitive and castration-resistant disease states.
- Castration-resistant prostate cancer therapies
- Novel hormonal agent combinations
- Targeted therapeutic approaches
Explores innovative treatment combinations including hormone therapy and targeted agents for advanced disease.
Kidney Cancer Studies
Leads investigations in renal cell carcinoma treatment, focusing on both clear cell and non-clear cell variants of the disease.
- Advanced renal cell carcinoma management
- Immunotherapy combinations
- Novel targeted therapies
Evaluates combination approaches involving immunotherapy and targeted agents for metastatic disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.